Budget Impact Analysis of Botulinum Toxin Type A Treatment for Cerebral Palsy In The Russian Federation

To conduct budget impact analysis of abobotulinumtoxinA+standard therapy, onabotulinumtoxinA+standard therapy and standard therapy solely in patients with spastic cerebral palsy (SCP) in Russia for 2-year period. Total number of patients with spastic cerebral palsy in Russia is 55 899.

Source: Value in Health - October 23, 2015 Category: Global & Universal Authors: R Yagudina, A Kulikov, D Ugrekhelidze Source Type: research